Drug Interaction Report

Treprostinil and Sertraline: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Treprostinil

Orenitram Orenitram® Remodulin Tyvaso Yutrepia
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 54 documented Treprostinil interactions, 43 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Using sertraline with treprostinil can add up to a higher bleeding risk, so watch for unusual bruising or bleeding and keep taking both as prescribed while your care team monitors you.

Taking sertraline and treprostinil together can raise your chance of bleeding or bruising more easily. Here is why: sertraline (an antidepressant) lowers the amount of serotonin your platelets use to help form clots, and treprostinil also makes platelets less sticky. Put them together and blood may clot a little less easily.

This doesn't mean something bad will happen, but it's worth watching for things like nosebleeds, easy bruising, or bleeding that won't stop. The good news is your care team can manage this by keeping an eye on you. Please don't stop either medicine on your own, but do tell your doctor or pharmacist if you notice more bleeding than usual.

Effect: Additive pharmacodynamic bleeding risk when sertraline is combined with treprostinil (a prostacyclin analog with antiplatelet activity). Neither drug is a prodrug; this is a PD interaction, not a PK one.

Mechanism: SSRIs deplete platelet serotonin, impairing platelet aggregation; treprostinil independently inhibits platelet function. The result is additive antihemostatic effect.

Evidence: Theoretical for this specific pair, though SSRI-plus-antiplatelet bleeding risk is supported by case-control and cohort data. Severity rated major.

  • Monitor for epistaxis, ecchymosis, hematoma, petechiae, and any signs of significant hemorrhage.
  • Counsel the patient on bleeding precautions; no fixed dose adjustment defined.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

Care should be taken when an SSRI is given together with an antiplatelet drug, since the combination can heighten the likelihood of bleeding episodes32. Using sertraline alongside an antiplatelet may amplify bleeding risk, an effect that may stem from sertraline's influence on platelet serotonin release. Data from case-control and cohort investigations have linked the joint use of selective serotonin and norepinephrine reuptake inhibitors (sertraline among them) with antiplatelet agents to a greater bleeding risk. Among the bleeding events documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening. If sertraline and an antiplatelet agent are administered at the same time, watch the patient for indications of heightened bleeding and advise patients about the elevated bleeding risk1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination can be managed with awareness and monitoring.

What your team typically does:

  • Watches you more closely for signs of bleeding.
  • Reminds you about bleeding precautions.

What you can do:

  • Watch for nosebleeds, easy or unusual bruising, tiny red skin spots, or bleeding that won't stop.
  • Report any of these to your pharmacist or prescriber promptly.
  • Ask before adding other blood thinners or NSAIDs like ibuprofen or aspirin.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

3 reports — tap to read

a) A retrospective study involving patients older than 50 years who were diagnosed with acute myocardial infarction (N=27,058) found that using an SSRI together with any antiplatelet treatment raised the bleeding risk significantly, by 1.42-fold, relative to aspirin alone. Treatment combining aspirin, clopidogrel, and an SSRI significantly elevated the risk by 2.35-fold compared with aspirin alone and by 1.57-fold compared with the combination of clopidogrel and aspirin 2.

b) In a systematic review and meta-analysis covering 22 observational studies, SSRI use was linked to a significant 1.55-fold rise in the risk of upper gastrointestinal bleeding (UGIB). Using SSRIs together with antiplatelet drugs was linked to a 2.48-fold rise in UGIB risk (3 studies) 3.

c) Case reports along with epidemiological studies (both case-control and cohort designs) have shown a link between the use of agents that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Drawing on published observational data, exposure to SSRIs, especially during the month prior to delivery, has been linked to a less than 2-fold rise in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have spanned from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.

Common questions

Can I take Treprostinil and Sertraline together?

Using sertraline with treprostinil can add up to a higher bleeding risk, so watch for unusual bruising or bleeding and keep taking both as prescribed while your care team monitors you. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Treprostinil and Sertraline interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Treprostinil and Sertraline interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination can be managed with awareness and monitoring. What your team typically does: Watches you more closely for signs of bleeding. Reminds you about bleeding precautions. What you can do: Watch for nosebleeds, easy or unusual bruising, tiny red skin spots, or bleeding that won't stop. Report any of these… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Treprostinil or Sertraline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.